|
|
 |
|
Viewing report
|
|
|
|
Amylin Pharmaceuticals, Inc. - SWOT Analysis
MarketLine, Oct 2011, Pages: 32
Amylin Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Amylin Pharmaceuticals, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Amylin Pharmaceuticals (Amylin), a biopharmaceutical company, engaged in the development of potential therapies to treat diabetes and obesity. It has developed and gained approval for Byetta and Symlin, for the treatment of diabetes. Amylin primarily operates in the US and Germany. The company is headquartered in San Diego, California, and employed about 300 people as of December 31, 2010. The company recorded revenues of $668.8 million during the financial year (FY) ended December 2010, a decrease of 11.8% over FY2009. The operating loss of the company was $126.7 million during FY2010, as compared to the operating loss of $173.3 million in FY2009. The net loss was $152.3 million in FY2010, as compared to a net loss of $186.3 million in FY2009.
Scope of the Report
- Provides all the crucial information on Amylin Pharmaceuticals, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Amylin Pharmaceuticals, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Amylin Pharmaceuticals, Inc.
-Data is supplemented with details on Amylin Pharmaceuticals, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Amylin Pharmaceuticals, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
|
